News

The Food and Drug Administration last week authorized marketing of a rapid diagnostic test to detect Ebola virus antigens in human blood from certain living individuals as well as samples from those recently deceased who are suspected to have died from Ebola.

The Food and Drug Administration Oct. 11 approved a new tablet for the acute treatment of migraine headache pain.

The AHA is accepting nominations through Nov. 25 for its 2020 Dick Davidson NOVA Award, which recognizes outstanding collaboration by hospitals and health systems for healthier communities.

“Get vaccinated” is a message everyone should hear, and hospitals and health systems are the ideal partners to spread it.

A federal judge in Washington state today blocked nationwide a Department of Homeland Security final rule from taking effect that would limit the ability of legal immigrants to adjust or extend their immigration status or gain full citizenship based on their prospective receipt of public benefits.

The Centers for Disease Control and Prevention today released updated interim clinical guidance for U.S. health care providers evaluating and caring for patients with lung injury associated with use of electronic cigarette or vaping products.

The AHA today urged the Drug Enforcement Administration to explicitly consider drug shortages when setting and adjusting aggregate production quotas, citing concern that the agency’s proposal to reduce 2020 production quotas for five opioid controlled substances would exacerbate shortages of injectable opioid medications.

The Centers for Medicare & Medicaid Services should require states that propose Medicaid work requirements and other demonstrations to project the cost of administering them, the Government Accountability Office said in a report released yesterday.

The Centers for Medicare & Medicaid Services today published its star ratings for 2020 Medicare Advantage and prescription drug plans.

The Centers for Disease Control and Prevention this week reported a record 2.5 million cases of chlamydia, gonorrhea and syphilis in the U.S. in 2018, including a 40% increase in syphilis among newborns.

The AHA is proud to be your partner in keeping your data — and your patients — safe.

The Centers for Medicare & Medicaid Services has updated its alternative payment model participation status tool for the 2019 Quality Payment Program, which identifies eligible clinicians who qualify as advanced APM participants based on Medicare Part B claims data through June.

The Department of Health and Human Services today released a guide to help clinicians who are contemplating or initiating a reduction in opioid dosage or discontinuation of long-term opioid therapy for chronic pain.

AHA President and CEO Rick Pollack today addressed the National Association of Health Services Executives at its annual educational conference in Washington, D.C., where he stressed the importance of advancing health equity in America. 

As long advocated by the AHA, the Department of Health and Human Services today proposed modernizing the Stark Law on physician self-referral and the Anti-kickback Statute.

The AHA today submitted recommendations to the Health Resources and Services Administration in response to the agency’s Rural Access to Health Care Services Request for Information.

The California Office of Statewide Health Planning and Development recently released the nation’s first mandatory data on wholesale acquisition cost increases for prescription drugs.

Net price increases for seven drugs raised U.S. drug spending by $5.1 billion between 2017 and 2018 without evidence of improved safety or effectiveness.

Only one in three U.S. pregnant women receive both the flu and whooping cough vaccines as recommended, according to a Vital Signs report released today by the Centers for Disease Control and Prevention.

The Centers for Medicare & Medicaid Services will add a new icon to the Nursing Home Compare website to indicate facilities cited for abuse on inspection reports.